Anemia and Heart Failure: A Community Study

Shannon M Dunlay, Susan A. Weston, Margaret May Redfield, Jill M. Killian, Veronique Lee Roger

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Purpose: Anemia is an important comorbidity in heart failure and has been associated with increased mortality. The goals of this study were to define the prevalence of anemia in a community population with heart failure, examine trends in prevalence over time, and evaluate the role of anemia in patients with heart failure with preserved and reduced ejection fraction. Methods: Two cohorts of Olmsted County residents with heart failure were examined. The retrospective cohort included incident heart failure cases from 1979 to 2002 (n = 1063). The prospective cohort included active heart failure cases from 2003 to 2006 (n = 677). Clinical characteristics were collected. Anemia was defined by World Health Organization criteria. Results: The prevalence of anemia was 40% in the retrospective cohort and 53% in the prospective cohort. Anemia prevalence increased by an estimated 16% between 1979 and 2002 (P = .008) and was higher in those with preserved (≥50%) versus reduced (<50%) ejection fraction (58% vs 48%, respectively, P < .001) from 2003 to 2006. Anemia was associated with a large increase in the risk of death (P < .001 both cohorts). The relationship between mortality and hemoglobin followed a J-shaped curve, with increased mortality with hemoglobin levels less than 14 mg/dL and greater than 16 mg/dL. In the prospective cohort, after adjustment for clinical characteristics, the hazard ratios (95% confidence interval) for death were 3.07 (1.26-6.82) in those with a hemoglobin level of 16 mg/dL or more and 2.39 (1.37-4.27) in those with a hemoglobin level less than 10 mg/dL, using hemoglobin 14 to 16 mg/dL as the referent. Conclusion: In the community, half of patients with heart failure are anemic, and the prevalence of anemia has increased over time. Anemia is more prevalent in heart failure with preserved ejection fraction and is associated with a large increase in mortality.

Original languageEnglish (US)
Pages (from-to)726-732
Number of pages7
JournalAmerican Journal of Medicine
Volume121
Issue number8
DOIs
StatePublished - Aug 2008

Fingerprint

Anemia
Heart Failure
Hemoglobins
Mortality
Comorbidity
Confidence Intervals
Population

Keywords

  • Anemia
  • Epidemiology
  • Heart failure
  • Hemoglobin
  • Mortality
  • Prevalence

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Anemia and Heart Failure : A Community Study. / Dunlay, Shannon M; Weston, Susan A.; Redfield, Margaret May; Killian, Jill M.; Roger, Veronique Lee.

In: American Journal of Medicine, Vol. 121, No. 8, 08.2008, p. 726-732.

Research output: Contribution to journalArticle

@article{8f2e05745e8b4b56a4711195c32f6053,
title = "Anemia and Heart Failure: A Community Study",
abstract = "Purpose: Anemia is an important comorbidity in heart failure and has been associated with increased mortality. The goals of this study were to define the prevalence of anemia in a community population with heart failure, examine trends in prevalence over time, and evaluate the role of anemia in patients with heart failure with preserved and reduced ejection fraction. Methods: Two cohorts of Olmsted County residents with heart failure were examined. The retrospective cohort included incident heart failure cases from 1979 to 2002 (n = 1063). The prospective cohort included active heart failure cases from 2003 to 2006 (n = 677). Clinical characteristics were collected. Anemia was defined by World Health Organization criteria. Results: The prevalence of anemia was 40{\%} in the retrospective cohort and 53{\%} in the prospective cohort. Anemia prevalence increased by an estimated 16{\%} between 1979 and 2002 (P = .008) and was higher in those with preserved (≥50{\%}) versus reduced (<50{\%}) ejection fraction (58{\%} vs 48{\%}, respectively, P < .001) from 2003 to 2006. Anemia was associated with a large increase in the risk of death (P < .001 both cohorts). The relationship between mortality and hemoglobin followed a J-shaped curve, with increased mortality with hemoglobin levels less than 14 mg/dL and greater than 16 mg/dL. In the prospective cohort, after adjustment for clinical characteristics, the hazard ratios (95{\%} confidence interval) for death were 3.07 (1.26-6.82) in those with a hemoglobin level of 16 mg/dL or more and 2.39 (1.37-4.27) in those with a hemoglobin level less than 10 mg/dL, using hemoglobin 14 to 16 mg/dL as the referent. Conclusion: In the community, half of patients with heart failure are anemic, and the prevalence of anemia has increased over time. Anemia is more prevalent in heart failure with preserved ejection fraction and is associated with a large increase in mortality.",
keywords = "Anemia, Epidemiology, Heart failure, Hemoglobin, Mortality, Prevalence",
author = "Dunlay, {Shannon M} and Weston, {Susan A.} and Redfield, {Margaret May} and Killian, {Jill M.} and Roger, {Veronique Lee}",
year = "2008",
month = "8",
doi = "10.1016/j.amjmed.2008.03.039",
language = "English (US)",
volume = "121",
pages = "726--732",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Anemia and Heart Failure

T2 - A Community Study

AU - Dunlay, Shannon M

AU - Weston, Susan A.

AU - Redfield, Margaret May

AU - Killian, Jill M.

AU - Roger, Veronique Lee

PY - 2008/8

Y1 - 2008/8

N2 - Purpose: Anemia is an important comorbidity in heart failure and has been associated with increased mortality. The goals of this study were to define the prevalence of anemia in a community population with heart failure, examine trends in prevalence over time, and evaluate the role of anemia in patients with heart failure with preserved and reduced ejection fraction. Methods: Two cohorts of Olmsted County residents with heart failure were examined. The retrospective cohort included incident heart failure cases from 1979 to 2002 (n = 1063). The prospective cohort included active heart failure cases from 2003 to 2006 (n = 677). Clinical characteristics were collected. Anemia was defined by World Health Organization criteria. Results: The prevalence of anemia was 40% in the retrospective cohort and 53% in the prospective cohort. Anemia prevalence increased by an estimated 16% between 1979 and 2002 (P = .008) and was higher in those with preserved (≥50%) versus reduced (<50%) ejection fraction (58% vs 48%, respectively, P < .001) from 2003 to 2006. Anemia was associated with a large increase in the risk of death (P < .001 both cohorts). The relationship between mortality and hemoglobin followed a J-shaped curve, with increased mortality with hemoglobin levels less than 14 mg/dL and greater than 16 mg/dL. In the prospective cohort, after adjustment for clinical characteristics, the hazard ratios (95% confidence interval) for death were 3.07 (1.26-6.82) in those with a hemoglobin level of 16 mg/dL or more and 2.39 (1.37-4.27) in those with a hemoglobin level less than 10 mg/dL, using hemoglobin 14 to 16 mg/dL as the referent. Conclusion: In the community, half of patients with heart failure are anemic, and the prevalence of anemia has increased over time. Anemia is more prevalent in heart failure with preserved ejection fraction and is associated with a large increase in mortality.

AB - Purpose: Anemia is an important comorbidity in heart failure and has been associated with increased mortality. The goals of this study were to define the prevalence of anemia in a community population with heart failure, examine trends in prevalence over time, and evaluate the role of anemia in patients with heart failure with preserved and reduced ejection fraction. Methods: Two cohorts of Olmsted County residents with heart failure were examined. The retrospective cohort included incident heart failure cases from 1979 to 2002 (n = 1063). The prospective cohort included active heart failure cases from 2003 to 2006 (n = 677). Clinical characteristics were collected. Anemia was defined by World Health Organization criteria. Results: The prevalence of anemia was 40% in the retrospective cohort and 53% in the prospective cohort. Anemia prevalence increased by an estimated 16% between 1979 and 2002 (P = .008) and was higher in those with preserved (≥50%) versus reduced (<50%) ejection fraction (58% vs 48%, respectively, P < .001) from 2003 to 2006. Anemia was associated with a large increase in the risk of death (P < .001 both cohorts). The relationship between mortality and hemoglobin followed a J-shaped curve, with increased mortality with hemoglobin levels less than 14 mg/dL and greater than 16 mg/dL. In the prospective cohort, after adjustment for clinical characteristics, the hazard ratios (95% confidence interval) for death were 3.07 (1.26-6.82) in those with a hemoglobin level of 16 mg/dL or more and 2.39 (1.37-4.27) in those with a hemoglobin level less than 10 mg/dL, using hemoglobin 14 to 16 mg/dL as the referent. Conclusion: In the community, half of patients with heart failure are anemic, and the prevalence of anemia has increased over time. Anemia is more prevalent in heart failure with preserved ejection fraction and is associated with a large increase in mortality.

KW - Anemia

KW - Epidemiology

KW - Heart failure

KW - Hemoglobin

KW - Mortality

KW - Prevalence

UR - http://www.scopus.com/inward/record.url?scp=48549103362&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48549103362&partnerID=8YFLogxK

U2 - 10.1016/j.amjmed.2008.03.039

DO - 10.1016/j.amjmed.2008.03.039

M3 - Article

C2 - 18691487

AN - SCOPUS:48549103362

VL - 121

SP - 726

EP - 732

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 8

ER -